Article
Uveal Melanoma Patient-Derived Xenografts
1 Jan 2015
Abstract excerpt
The prognosis of uveal melanoma (UM) remains poor due to a high risk of metastatic disease. No effective therapies have been described for metastatic UM, and new therapies are needed to improve the outcome for these patients. To achieve this goal, new preclinical animal models are needed. Existing animal models, including genetically engineered mice and orthotopic xenograft models in immunodeficient animals, are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
